Pathogen inactivation in cellular blood components: clinical trials and implications of introduction to transfusion medicine.
AuBuchon
James P
JP
Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA. james.p.aubuchon@hitchcock.org
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents / Q000494:pharmacology* / Q000633:toxicity; D016913:Blood Component Transfusion / Q000009:adverse effects*; D001792:Blood Platelets / Q000382:microbiology; D017848:Blood-Borne Pathogens; D018562:Disease Transmission, Infectious / Q000517:prevention & control; D004912:Erythrocytes / Q000382:microbiology; D006801:Humans; D013242:Sterilization / Q000379:methods*
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents